Dawes Fretzin Dermatology Group

Indianapolis, Indiana 46256

0 studies enrolling now · 8 studies all time

What they study most

Atopic Dermatitis, CTCL, CTCL/ Mycosis Fungoides, Chronic Plaque Psoriasis, Cutaneous T Cell Lymphoma, Cutaneous T-Cell Lymphoma, Mycosis Fungoides, Plaque Psoriasis, Psoriasis

Studies at this site

• Confirmatory Study of Topical HyBryte™ vs. Placebo for the Treatment of CTCL — Stopped early
• Long-Term Study That Measures the Safety and Efficacy of Deucravacitinib (BMS-986165) in Participants With Psoriasis — Running, not enrolling
• Study Evaluating The Safety And Tolerability Of ILV-094 In Subjects With Psoriasis — Completed
• An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo and a Currently Available Treatment in Participants With Moderate-to-Severe Plaque Psoriasis — Completed
• FLASH [Fluorescent Light Activated Synthetic Hypericin] Clinical Study: Topical SGX301 (Synthetic Hypericin) for the Treatment of Cutaneous T-Cell Lymphoma (Mycosis Fungoides) — Completed
• A Phase 2, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Belumosudil in Subjects With Moderate/Severe Chronic Plaque Psoriasis — Completed
• Topical Application of BMX-010 in Subjects With Atopic Dermatitis and Plaque Psoriasis — Completed
• AGN-242428 in the Treatment of Plaque Psoriasis — Stopped early